Study reveals patients with obesity exposed to SARS-CoV-2 had higher odds of testing positive, suggesting obesity as an intrinsic risk factor for COVID-19 transmission and potentially influencing resource allocation strategies.
A study published in The Lancet found that semaglutide may reduce major adverse cardiovascular events and all-cause mortality in patients with obesity and heart failure, regardless of heart failure subtype.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Linpharma's Lyranda, a novel cold sore treatment available OTC, demonstrated a 5.7-fold increase in complete healing at 5 days compared to other therapies in clinical trials.
HPV-16, found in 59% of infected men's semen, may be linked to increased sperm necrosis and oxidative stress without altering routine sperm parameters.